BEPADIN Drug Patent Profile

When do Bepadin patents expire, and when can generic versions of Bepadin launch?

Bepadin is a drug marketed by Medpointe Pharm Hlc and is included in one NDA.

The generic ingredient in BEPADIN is bepridil hydrochloride. There are four drug master file entries for this compound. Additional details are available on the bepridil hydrochloride profile page.

Summary for BEPADIN

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	54
DailyMed Link:	BEPADIN at DailyMed

US Patents and Regulatory Information for BEPADIN

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Medpointe Pharm Hlc	BEPADIN	bepridil hydrochloride	TABLET;ORAL	019001-001	Dec 28, 1990		DISCN	No	No
Medpointe Pharm Hlc	BEPADIN	bepridil hydrochloride	TABLET;ORAL	019001-002	Dec 28, 1990		DISCN	No	No
Medpointe Pharm Hlc	BEPADIN	bepridil hydrochloride	TABLET;ORAL	019001-003	Dec 28, 1990		DISCN	No	No

Expired US Patents for BEPADIN

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Medpointe Pharm Hlc	BEPADIN	bepridil hydrochloride	TABLET;ORAL	019001-001	Dec 28, 1990	RE30577
Medpointe Pharm Hlc	BEPADIN	bepridil hydrochloride	TABLET;ORAL	019001-003	Dec 28, 1990	RE30577
Medpointe Pharm Hlc	BEPADIN	bepridil hydrochloride	TABLET;ORAL	019001-002	Dec 28, 1990	RE30577

International Patents for BEPADIN

See the table below for patents covering BEPADIN around the world.

Country	Patent Number	Title	Estimated Expiration
Netherlands	153190
Japan	S4899127
Switzerland	556815	PROCEDE POUR LA PREPARATION DES PROPYLAMINES.
South Africa	7301411
Germany	2310918
Belgium	795735
Netherlands	7303117

BEPADIN Market Analysis and Financial Projection Experimental

BEPADIN: Market Dynamics and Financial Trajectory

Introduction to BEPADIN

BEPADIN, a brand name for povidone iodine, is a widely used antiseptic and disinfectant. It is employed in various medical and consumer applications, including skin sterilization, infection prevention, and wound treatment.

Market Overview

The global povidone iodine market, which includes BEPADIN, is projected to experience significant growth. Here are some key market dynamics:

Market Size and Growth

The povidone iodine market is expected to reach a valuation of US$ 256.7 billion by 2030, growing at a compound annual growth rate (CAGR) of approximately 5% from 2020 to 2030[1].

Key Drivers

• Increased Awareness of Oral Health: Public and private initiatives have raised awareness about oral health, contributing to the demand for povidone iodine products.
• COVID-19 Pandemic: The pandemic has heightened the importance of skin sterilization, driving the demand for antiseptic products like BEPADIN.
• Diverse Applications: Povidone iodine is used in skin sterilization, infection prevention, instrument sterilization, and wound healing, broadening its market appeal[1].

Application Segments

Skin Sterilization

This segment is expected to see aggressive growth due to the increased need for skin sterilization, especially during the COVID-19 pandemic. BEPADIN's effectiveness in reducing microorganisms on the skin makes it a preferred choice[1].

Infection Prevention

Povidone iodine is widely used for presurgical vaginal irrigation to prevent postoperative wound infections and fever. This application is crucial in gynecological procedures and is a significant driver of the market[1].

Instrument Sterilization

The use of povidone iodine in sterilizing medical instruments is another key application, ensuring the safety and hygiene of medical procedures.

Regional Market Dynamics

North America

North America is a highly attractive region for vendors in the povidone iodine market due to advanced healthcare infrastructure and high demand for antiseptic products[1].

Asia Pacific

The Asia Pacific region is also seeing significant growth, driven by increasing healthcare spending and the need for effective antiseptic solutions. Countries like China and India are key markets within this region[1].

Competitive Landscape

The market for BEPADIN and other povidone iodine products is competitive, with key players including:

• Evonik Industries AG
• BASF SE
• Nippon Shokubai Co Ltd
• LG Chem Ltd
• Sumitomo Seika Chemicals Co. Ltd
• Sanyo Chemical Industries
• KAO Corporation[1].

Financial Trajectory

Revenue Growth

The revenue from povidone iodine products, including BEPADIN, is expected to rise significantly. The market's CAGR of 5% indicates a steady and promising financial trajectory[1].

Investment and Research

Companies are investing heavily in research and development to enhance the efficacy of povidone iodine. For example, in vitro and in vivo investigations of povidone iodine liposome hydrogel for topical wound treatment are underway, which could further boost market growth[1].

Challenges and Opportunities

Regulatory Environment

While the market is growing, it is also subject to stringent regulatory requirements. Compliance with these regulations can be a challenge but also presents opportunities for companies that can innovate and meet these standards.

Technological Advancements

Advances in technology, such as the development of new formulations and delivery methods, offer significant opportunities for growth. For instance, the use of povidone iodine in liposome hydrogel for wound treatment is a promising area of research[1].

Key Takeaways

• The povidone iodine market, including BEPADIN, is expected to reach US$ 256.7 billion by 2030.
• The market is driven by increased awareness of oral health, the COVID-19 pandemic, and diverse applications.
• Key regions include North America and the Asia Pacific.
• The competitive landscape is dominated by several major chemical and pharmaceutical companies.
• Continuous investment in research and development is crucial for market growth.

FAQs

What is the projected market size for povidone iodine by 2030?

The povidone iodine market is expected to reach a valuation of US$ 256.7 billion by 2030[1].

What are the key drivers of the povidone iodine market?

Key drivers include increased awareness of oral health, the COVID-19 pandemic, and diverse applications in skin sterilization, infection prevention, and wound healing[1].

Which regions are most attractive for povidone iodine vendors?

North America and the Asia Pacific are highly attractive regions due to their advanced healthcare infrastructure and growing demand for antiseptic products[1].

Who are the key players in the povidone iodine market?

Key players include Evonik Industries AG, BASF SE, Nippon Shokubai Co Ltd, LG Chem Ltd, Sumitomo Seika Chemicals Co. Ltd, Sanyo Chemical Industries, and KAO Corporation[1].

What are the potential challenges and opportunities in the povidone iodine market?

Challenges include regulatory compliance, while opportunities arise from technological advancements and increasing demand for antiseptic solutions[1].

Cited Sources:

1. Transparency Market Research, "Povidone Iodine Market | Global Industry Report, 2030".
2. BridgeBio Pharma, "BridgeBio Pharma Reports Third Quarter 2024 Financial Results".
3. BCC Research, "Antibody Drugs: Technologies and Global Markets".
4. BayernLB, "Press Release - BayernLB".